NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/12/2026
Back to search
Official data from USPTO
OPTIFORM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
08/12/2026
Trademark type
Word
Nice classes
42
Filing date
11/04/2015
Registration date
06/28/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2026
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/09/2010
First use in commerce
08/09/2010
Drawing code
4
Owner type
03
Owner location
Bridgewater, NJ, US
Examiner
CROWLEY, SEAN MICHAEL
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CATALENT PHARMA SOLUTIONS, INC.
CATALENT PHARMA SOLUTIONS, INC.
Representatives
Vanessa A. Ignacio, Esq. LOWENSTEIN SANDLER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research services; Chemical compound and chemical compound library research and development services; Pharmaceutical research and developmentscreening drug targets; Pharmaceutical research and developmentautomated screening of pharmaceutical and chemical compounds; Pharmaceutical products development; Pharmaceutical drug development services; Scientific and technological servicesscientific researchanalysisscreening and testing in the field of oral dose drug development; Conducting scientific feasibility studies; Pharmaceutical research servicesscreening and identifying optimal active pharmaceutical ingredient (API) formsoptimized final dosing formsdosing profilesoptimal formulation of pharmaceutical productsdetermination of drug substance state for enhanced bioavailabilityingredient compatibility screeningsolid state screening and comparative analytical testing of drug substance states; Consulting services in the fields of pharmaceutical product developmentoptimization of optimal active pharmaceutical ingredient (API) designformulation of pharmaceutical products and drug product design
Publications
History of USPTO decisions and trademark events.
22 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/12/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/12/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
06/15/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/28/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/25/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/13/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/13/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/13/2023
E815
TEAS SECTION 8 & 15 RECEIVED
06/28/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/28/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/22/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2016
PUBO
PUBLISHED FOR OPPOSITION
04/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2016
DOCK
ASSIGNED TO EXAMINER
02/26/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
11/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2015
NWAP
NEW APPLICATION ENTERED
11/07/2015
Continuous trademark protection
Get notified about every new filing that threatens OPTIFORM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.